SCYNEXIS, Inc.

DB:135A Stock Report

Market Cap: €44.9m

SCYNEXIS Management

Management criteria checks 2/4

SCYNEXIS' CEO is David Angulo, appointed in Jan 2023, has a tenure of 1.83 years. total yearly compensation is $1.21M, comprised of 46.5% salary and 53.5% bonuses, including company stock and options. directly owns 0.38% of the company’s shares, worth €170.37K. The average tenure of the management team and the board of directors is 2.1 years and 9.5 years respectively.

Key information

David Angulo

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage46.5%
CEO tenure1.8yrs
CEO ownership0.4%
Management average tenure2.1yrs
Board average tenure9.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has David Angulo's remuneration changed compared to SCYNEXIS's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$36m

Jun 30 2024n/an/a

-US$35m

Mar 31 2024n/an/a

US$101m

Dec 31 2023US$1mUS$565k

US$67m

Sep 30 2023n/an/a

US$72m

Jun 30 2023n/an/a

US$44m

Mar 31 2023n/an/a

-US$91m

Dec 31 2022US$1mUS$482k

-US$63m

Sep 30 2022n/an/a

-US$78m

Jun 30 2022n/an/a

-US$49m

Mar 31 2022n/an/a

-US$34m

Dec 31 2021US$987kUS$461k

-US$33m

Sep 30 2021n/an/a

-US$46m

Jun 30 2021n/an/a

-US$45m

Mar 31 2021n/an/a

-US$53m

Dec 31 2020US$939kUS$447k

-US$55m

Sep 30 2020n/an/a

-US$27m

Jun 30 2020n/an/a

-US$36m

Mar 31 2020n/an/a

-US$38m

Dec 31 2019US$1mUS$437k

-US$54m

Sep 30 2019n/an/a

-US$37m

Jun 30 2019n/an/a

-US$29m

Mar 31 2019n/an/a

-US$31m

Dec 31 2018US$769kUS$424k

-US$12m

Sep 30 2018n/an/a

-US$22m

Jun 30 2018n/an/a

-US$31m

Mar 31 2018n/an/a

-US$24m

Dec 31 2017US$768kUS$412k

-US$25m

Compensation vs Market: David's total compensation ($USD1.21M) is above average for companies of similar size in the German market ($USD472.15K).

Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.

CEO

David Angulo (59 yo)

1.8yrs

Tenure

US$1,214,710

Compensation

Dr. David Gonzalez Angulo, M. D., had been the Chief Medical Officer at SCYNEXIS, Inc. since June 1, 2015. He is President, Director and Chief Executive Officer of SCYNEXIS, Inc. from January 1, 2023. Dr....

Leadership Team

NamePositionTenureCompensationOwnership
David Angulo
CEO, President & Director1.8yrsUS$1.21m0.38%
€ 170.4k
Ivor Macleod
Chief Financial Officer2.1yrsUS$626.90k0.028%
€ 12.4k
Scott Sukenick
Chief Legal Officer & Corporate Secretary7yrsUS$936.70k0.21%
€ 94.5k
Daniella Gigante
Vice President of Human Resources & Information Technologyno datano datano data

2.1yrs

Average Tenure

59yo

Average Age

Experienced Management: 135A's management team is considered experienced (2.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
David Angulo
CEO, President & Director1.8yrsUS$1.21m0.38%
€ 170.4k
Armando Anido
Independent Director5.8yrsUS$98.75k0.066%
€ 29.6k
David Hastings
Independent Director9.2yrsUS$104.25k0.061%
€ 27.4k
Ann Hanham
Independent Director15.9yrsUS$105.25k0.062%
€ 28.0k
Guy MacDonald
Independent Chairman of the Board10yrsUS$128.75k0.084%
€ 37.9k
Steven Gilman
Independent Director9.8yrsUS$106.25k0.063%
€ 28.4k
David Denning
Member of Scientific Advisory Boardno datano datano data
Peter Pappas
Member of Scientific Advisory Boardno datano datano data
Oliver Cornely
Member of Scientific Advisory Boardno datano datano data
Barbara Alexander
Member of Scientific Advisory Boardno datano datano data
Mahmoud Ghannoum
Member of Scientific Advisory Boardno datano datano data
Paul Nyirjesy
Member of Scientific Advisory Boardno datano datano data

9.5yrs

Average Tenure

65.5yo

Average Age

Experienced Board: 135A's board of directors are considered experienced (9.5 years average tenure).